Bringing Cure...Building Hope...
Home | Blog | Events
Pharma legitimate consultant and facilitator in Delhi India

Oncology Drugs Approved For
Lymphoma by US FDA

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

Get Access to FDA Approved Drugs / Anti-Cancer Medicines
For Lymphoma Treatment in India

Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control. Treatment depends on stage:- Treatment may involve chemotherapy, medication, radiation therapy and rarely stem-cell transplant.

The following lists anti-cancer drugs, US FDA and Indian Generic brand approved by the Food and Drug Administration (FDA) for Lymphoma treatment. The list includes generic and brand names are in some way related to, or used in the treatment of this condition. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

ALIQOPA

ALIQOPA (copanlisib) for injection, for intravenous use. Initial U.S. Approval: 2017.

More Details...
ADCETRIS

ADCETRIS (brentuximab vedotin) for injection, for intravenous use Initial U.S. approval: 2011.

More Details...
BRUKINSA

BRUKINSA (zanubrutinib) capsules, for oral use. Initial U.S. Approval: 2019

More Details...
CALQUENCE

CALQUENCE (acalabrutinib) capsules, for oral use initial u.s. approval: 2017.

More Details...
FOLOTYN

FOLOTYN (pralatrexate injection) Solution for intravenous injection. Initial U.S. Approval: 2009

More Details...
IBRUNAT

IBRUNAT (ibrutinib) capsules, for oral use Initial U.S. Approval: 2013

More Details...
IMBRUVICA

IMBRUVICA (ibrutinib) oral suspension Initial U.S. Approval: 2013

More Details...
RITUXAN

RITUXAN (rituximab) Injection for Intravenous Use Initial U.S. Approval: 1997

More Details...
ROMIDEPSIN

ROMIDEPSIN for injection For intravenous infusion only. Initial US Approval: 2009

More Details...
POLIVY

POLIVY (polatuzumab vedotin-piiq) for injection, for intravenous use Initial U.S. Approval: 2019

More Details...
TAZVERIK

TAZVERIK (tazemetostat) tablets, for oral use Initial U.S. Approval: 2020

More Details...
ZOLINZA

ZOLINZA (vorinostat) Capsules Initial U.S. Approval: 2006

More Details...

Your Query Form

Head Office

Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi, New Delhi:110016 India.

Mobile / WhatsApp Number:
Mobile: +91-9891296838 / 9811747774
WhatsApp: +91-9891296838 / 9811747774

Contact Details:
Phone: +91-11-26532129 / 26536398
Fax: +91-11-26532129 / 26536398

E Mail:
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Social Media:
Note:-

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India.Helps you to access FDA approved Lymphoma medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Lymphoma Medicines in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

If you have a question relating to anti-cancer medicines approved for treatment of Lymphoma, a problem which you do not know how to resolve it, or concrete inquiry - we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Indian Pharma Network, New Delhi. India

IPN, Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals.
Specialized in Oncology and other pharma products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Mumbai | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur | Punjab | Chandigarh
Our Overseas Network Uk | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

US FDA Approved Oncology Drugs

For Leukemia

The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.

US FDA Approved Oncology Drugs

For Multiple Myeloma

The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.

Indian FDA Approved Oncology Drugs

For Melanoma

The list includes FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.